INVA
Innoviva Inc
21.10$
+1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.7% | 27.7% | 24.6% | 29.2% | 32.5% | 42.6% | 46.4% | 48.9% | 47.9% | 44.5% | 42.1% | 44.2% | |
| 15.1% | 15.6% | 14.1% | 17.7% | 21.2% | 23.4% | 25.4% | 29.8% | 33.3% | 33.7% | 32.8% | 33.5% | |
| 15.1% | 15.6% | 14.1% | 17.7% | 21.2% | 31.7% | 35.6% | 37.3% | 37.3% | 33.7% | 33.3% | 34.0% | |
| 5.7% | 6.8% | 6.0% | 7.7% | 7.4% | 6.6% | 6.2% | 6.6% | 6.5% | 2.1% | 5.0% | 6.5% | |
| 3.4% | 3.3% | 3.0% | 3.0% | 2.8% | 2.6% | 3.3% | 3.7% | 2.7% | 2.4% | 2.1% | 2.3% | |
| 1.5% | 1.4% | 1.4% | 1.5% | 1.5% | 1.4% | 1.4% | 1.3% | 1.3% | 1.1% | 1.0% | 1.1% | |
| 19.9% | 18.5% | 17.7% | 17.8% | 17.1% | 16.0% | 16.1% | 14.7% | 13.0% | 11.1% | 9.6% | 9.9% | |
| 47.2% | 45.7% | 44.5% | 45.7% | 45.7% | 46.9% | 48.4% | 46.4% | 29.3% | 28.3% | 26.9% | 27.6% | |
| 3.0% | 3.1% | 2.4% | 2.3% | 18.2% | 18.1% | 18.7% | 18.5% | 3.4% | 3.0% | 2.0% | 2.8% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 15.7% | 14.9% | 15.4% | 14.5% | 0.6% | 0.0% | 0.3% | 0.0% | |
| 0.3% | 0.5% | 0.1% | 0.2% | 0.3% | 0.2% | 0.4% | 0.4% | 0.4% | 0.3% | 0.4% | 0.2% | |
| 37.5% | 35.9% | 35.2% | 36.5% | 20.8% | 19.7% | 20.5% | 19.3% | 18.0% | 15.8% | 14.1% | 15.2% | |
| 52.8% | 54.3% | 55.5% | 54.3% | 54.3% | 53.1% | 51.6% | 53.6% | 70.7% | 71.7% | 73.1% | 72.4% | |
| -7.3% | -2.0% | 0.9% | -1.9% | -1.8% | -0.1% | -3.9% | 1.1% | 7.4% | 16.5% | 24.8% | 21.9% | |
| 7.3% | 6.8% | 6.7% | 5.1% | 5.1% | 6.5% | 5.0% | 6.3% | 5.9% | 5.2% | 4.6% | 4.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.